Use App
  • Trending
  • News
  • Earnings
DIADIA1.99%
SPYSPY1.87%
QQQQQQ3.51%
Trending
Top trending tickerADBEADBE11.94%
RDWRDW24.14%
ASTSASTS16.26%
SPACZZXSPACZZX0.60%
NASANASA18.12%
VELOVELO44.00%
SNDKSNDK16.11%
SATSSATS16.81%
PWRL28.34%
RHRH6.26%
Top trending tickerADBEADBE11.94%
RDWRDW24.14%
ASTSASTS16.26%
SPACZZXSPACZZX0.60%
NASANASA18.12%
VELOVELO44.00%
SNDKSNDK16.11%
SATSSATS16.81%
PWRL28.34%
RHRH6.26%
homeSymbolINKT
INKT logo

INKTMiNK Therapeutics Inc

$12.58
$0.145
(1.19%)
Today
·Closed $12.34
$0.245
(1.99%)
After Hours
Updated: 05:46 PM EDT
Reported EarningsMay 15
Mkt Cap$60.73M
Vol108,841.00

Fundamentals

Mkt Cap
$60.73M
Volume
-
52W High
$76.00
52W Low
$6.80
PE Ratio
-4.29
Avg. Volume
39,470.19
EPS (Annual)
-$2.93
P/B
-4.77
Rev/Employee
$0.00
Earnings
May 15

Feed

News

Sentiment

Earnings

Fundamentals

Info

Advertisement|Remove ads.

Latest INKT News

View
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
PR Newswire
News Placeholder
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
Business Wire
News Placeholder
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
Business Wire
News Placeholder
Loading...

Advertisement|Remove ads.

Advertisement|Remove ads.

TrendingNews
CommunityProfile